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OBJECTIVE—To investigate how insulin sensitivity and glu-
cose metabolism differ in adipocytes between different fat depots
of male and female mice and how sex steroids contribute to
these differences.
RESEARCH DESIGN AND METHODS—Adipocytes from in-
tra-abdominal/perigonadal (PG) and subcutaneous (SC) adipose
tissue from normal, castrated, or steroid-implanted animals were
isolated and analyzed for differences in insulin sensitivity and
glucose metabolism.
RESULTS—Adipocytes from both PG and SC depots of females
have increased lipogenic rates compared with those from males.
In females, intra-abdominal PG adipocytes are more insulin-
sensitive than SC adipocytes and more insulin-sensitive than
male adipocytes from either depot. When stimulated by low
physiological concentrations of insulin, female PG adipocytes
show a robust increase in Akt and extracellular signal–related
kinase (ERK) phosphorylation and lipogenesis, whereas male
adipocytes show activation only at higher insulin concentrations.
Adipocytes from females have higher mRNA/protein levels of
several genes involved in glucose and lipid metabolism. After
castration, adipocytes of male mice showed increased insulin
sensitivity and increased lipogenic rates, whereas adipocytes of
females demonstrate decreased lipid production. Increasing es-
trogen above physiological levels, however, also reduced lipid
synthesis in females, whereas increasing dihydrotestosterone in
males had no effect.
CONCLUSIONS—There are major sex differences in insulin
sensitivity in adipose tissue, particularly in the intra-abdominal
depot, that are regulated by physiological levels of sex steroids.
The increased sensitivity to insulin and lipogenesis observed in
adipocytes from females may account for their lower level of
insulin resistance and diabetes risk despite similar or higher fat
content than in males. Diabetes 58:803–812, 2009
O
besity increases dramatically the probability of
developing type 2 diabetes, dyslipidemia, car-
diovascular disease, fatty liver, and even some
types of cancer (1). This occurs in large part as
a result of decreased sensitivity of tissues to insulin, that
is, insulin resistance. Adipocytes in different fat depots
appear to have a distinct impact in insulin sensitivity.
Accumulation of visceral fat is linked to the development
of these metabolic complications, whereas accumulation
of subcutaneous fat is not (2–4).
Fat accumulation in different depots is also sexually
dimorphic. In humans, men accumulate more visceral fat,
whereas women accumulate more subcutaneous fat and
have a higher percentage of body fat compared with men.
There is also evidence indicating that insulin sensitivity
differs between males and females (5,6). Thus, despite
having lower fat mass, the prevalence of diabetes and
early abnormalities of glucose metabolism is higher in men
than in women (7). Women also have decreased suscepti-
bility to fatty acid–induced peripheral insulin resistance
(8). In different rodent models of glucose intolerance,
insulin resistance, and diabetes, males show a stronger
phenotype than females (9–11). These sex-related differ-
ences in insulin sensitivity and adipose tissue development
and function could be attributable in part to actions of
estrogen and testosterone. For example, decreases in
estrogen and increases in testosterone levels that occur
during menopause are associated with loss of subcutane-
ous and gain of visceral fat and increase in insulin resis-
tance (12). However, how insulin action differs between
males and females and how these differences account for
a sex-speciﬁc regulation of adipose tissue development
and function are largely unknown.
In this study, we have investigated how insulin sensitiv-
ity and glucose metabolism differ in adipocytes from
visceral and subcutaneous depots between male and fe-
male mice and how sex steroids could contribute to these
differences. We ﬁnd sex-speciﬁc differences in insulin
action in adipocytes that may contribute to the sexual
dimorphism of insulin resistance and suggest the possibil-
ity of more effective sex-speciﬁc therapies for obesity,
diabetes, and metabolic syndrome.
RESEARCH DESIGN AND METHODS
Animals and physiological measurements. C57BL/6 mice obtained from
Taconic Laboratories were used between 9 and 15 weeks of age. Mice (9
weeks old) were castrated, sham operated, or implanted with 1.5 mg dihy-
drotestosterone (males) or 0.1 mg 17-estradiol (females) pellets in a slow (21
days) release form. Glucose tolerance tests and insulin tolerance tests were
performed on 9- and 12-week-old mice, respectively. Leptin, adiponectin, free
fatty acid (FFA), estradiol, and dihydrotestosterone (DHT) serum levels were
determined using ELISA. All protocols for animal use and euthanasia were
approved by the Animal Care Use Committee of the Joslin Diabetes Center in
accordance with National Institutes of Health guidelines.
Adipocyte isolation and lipogenesis. Adipocytes from perigonadal (PG)
and ﬂank inguinal subcutaneous (SC) adipose depots from each individual
mouse were isolated by collagenase digestion (13). Lipogenesis assays were
performed as described in the online appendix (available at http://diabetes.
diabetesjournals.org/cgi/content/full/db09-1054/DC1). To assess cell number,
aliquots of 200 l adipocytes were ﬁxed with osmic acid and counted in a
Coulter counter (14).
Gene expression. Total RNA was extracted from 100 l of isolated adipo-
cytes (Rneasy; QIAGEN). Reverse transcription was performed using 0.5 go f
RNA, and quantitative real-time PCR was performed using a ﬂuorescent
temperature cycler (ABI 7900) with SYBR Green.
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DIABETES, VOL. 58, APRIL 2009 803Western blot. Isolated adipocytes were treated with or without 0.1 or 10
nmol/l insulin for 5–30 min. Proteins were extracted from 200 l of cell
suspension homogenized in radioimmunoprecipitation assay buffer with 1%
SDS. Thirty to 50 g of protein was subjected to SDS-PAGE, transferred to
polyvinylidine ﬂuoride membranes, and blots were probed with the respective
antibodies. The antigen-antibody complex was detected by using the HRP-
coupled secondary antibodies and enhanced chemiluminescence.
Data are reported as means  SEM. Comparisons for the glucose tolerance
test, insulin tolerance test, and lipogenesis experiments were made using
repeated-measures ANOVA and the rest of the comparisons were made using
Student’s t test; P  0.05 was considered signiﬁcant.
RESULTS
Female mice and female adipocytes are more insulin-
sensitive than males. Previous studies have suggested
that female humans and rodents are more insulin-sensitive
FIG. 1. Female mice and female adipocytes have increased insulin sensitivity. Glucose tolerance test was performed after an overnight fast. Mice
received an intraperitoneal injection of 2 g/kg body wt glucose. Blood glucose was measured from tail vein samples at the indicated times (A).
Insulin tolerance test was performed on random-fed mice. Animals received injections of 1 unit/kg body wt insulin. Blood glucose was measured
at the indicated time points (B). Data points are means  SE with eight mice in each group. Adipocytes from PG and SC fat were isolated from
male and female mice and stimulated with or without insulin in the presence of
14C-glucose for 90 min as described in RESEARCH DESIGN AND METHODS.
Radioactive glucose incorporated into lipids was measured for each condition in the extracted lipids and normalized to total lipid content (C)o r
to cell number (D) as determined by counting of osmic acid ﬁxed cells, n  3. **P < 0.01 by repeated-measures ANOVA. *P < 0.05 by Student’s
t test for point-to-point comparisons.
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subjected to intraperitoneal glucose tolerance tests, fe-
male mice had lower glucose levels than male mice at
every time point (P  0.05) (Fig. 1A), suggesting increased
insulin sensitivity. This was conﬁrmed by insulin tolerance
tests, which showed a greater fall in blood glucose in
response to insulin in female as compared with male mice
(Fig. 1B).
To analyze how glucose and lipid metabolism differ
between male and female adipocytes, we measured the
ability of isolated adipocytes to synthesize lipids through
de novo lipogenesis. Under both basal and insulin-stimu-
lated conditions, female adipocytes from PG and inguinal
SC depots showed increased lipid synthesis as compared
with male adipocytes whether expressed by lipid content
(PG, P  0.0001) (Fig. 1C) or by cell number (PG, P 
0.001; SC, P  0.01) (Fig. 1D). The difference between
sexes for PG fat was 263% (P  0.005) in the basal state
and 225% at maximal insulin concentration (P  0.001).
Female adipocytes from the PG depot also showed in-
creased insulin sensitivity when compared with male
adipocytes from the same depot. The insulin concentra-
tion causing a half maximal effect (EC50) on lipogenesis in
female adipocytes from the PG depot was 0.19  0.12
nmol/l, whereas in male adipocytes, it was 3.5 times
higher, 0.67  0.11 nmol/l (P  0.001). Subcutaneous
adipocytes from males and females showed a smaller
difference in basal and insulin-stimulated effect than the
PG fat that was statistically signiﬁcant when normalized
by cell number (P  0.01); however, no difference in
insulin sensitivity was observed between male and female
adipocytes from the SC depot (Fig. 1C–D).
Adipocytes from female mice have increased insulin
stimulation of Akt and extracellular signal–related
kinase. To determine whether the increased insulin sen-
sitivity in female adipocytes observed in lipogenesis was a
result of increased insulin signaling, we assessed phos-
phorylation/activation of two insulin downstream targets,
FIG. 2. Increased insulin-stimulated Akt and ERK activation in female adipocytes. Adipocytes from PG fat isolated from male and female mice
were treated with or without 10 nmol/l (A) or 0.1 nmol/l (B and C) insulin for 5 (A–C)o r3 0m i n( C). Cell lysates were run on SDS-PAGE and
subjected to Western blot analysis using antibodies directed against phosphorylated (pAkt Ser473, pERK Thr202/Tyr204) or total Akt and ERK.
Each lane represents a pool of adipocytes from three to four mice. The data were also quantiﬁed by densitometric scanning of the autoradiographs
(n  2). *P < 0.05-fold stimulation females versus males.
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two different doses of insulin: a low physiological dose (0.1
nmol/l) and a pharmacological dose (10 nmol/l). This
revealed that high insulin concentrations for 5 min in-
duced a similar level of Akt and ERK phosphorylation in
both female and male adipocytes (Fig. 2A). By contrast,
stimulation with the low insulin concentration for 5 or 30
min (Fig. 2B and C) induced a robust increase in Akt and
ERK phosphorylation only in female adipocytes (7.1- to
11.1-fold for Akt and 3.9- to 13.9-fold for ERK) (Fig. 2B and
C), whereas the same physiological concentration of insu-
lin induced only a very modest effect (1.2- to 1.62-fold for
Akt and 0.9- to 1.3-fold for ERK) (Fig. 2B and C)o rn o
activation in male adipocytes (P  0.05 for both Akt and
ERK).
Female adipocytes show higher expression of glucose
and lipid metabolism genes. To determine whether
differences in expression could explain the increased
lipogenic activity and the increased insulin signaling in
female adipocytes, we analyzed the mRNA expression
patterns of genes involved in insulin signaling and in
glucose and lipid metabolism using quantitative RT-PCR.
We observed that adipocytes from both depots from
female mice had higher mRNA levels of the glucose
transporters (GLUT1, GLUT4) and the key lipogenic en-
zymes fatty acid synthase (FAS) and acetyl CoA carboxy-
lase (ACC) than male adipocytes from the same depots
(Fig. 3A). ACC mRNA showed a 4.3- and 2.1-fold difference
between male and female cells for PG and SC fat (P 
0.05). Likewise, FAS mRNA was 2.7-fold higher in both
depots in female versus male adipocytes (P  0.05).
GLUT4 was 2.4-fold (PG) and 1.5-fold (SC) higher in
females, and GLUT1 was 2.4-fold (PG) and 1.8-fold (SC)
higher in female adipocytes (P  0.05). mRNA levels for
each of these genes tended to be higher in female PG
adipocytes than in SC adipocytes such that the female PG
depot had the highest levels of expression of these genes
among all depots compared. In males, the expression
levels were similar between the two depots.
These differences in mRNA were paralleled by differ-
ences in protein expression as determined by Western blot
analysis. Thus, protein levels of GLUT4, ACC, and FAS
were higher in female than in male adipocytes by two- to
threefold (P  0.05). By contrast, the insulin receptor and
actin levels were not different (Fig. 3B and C). Thus, the
greater level of lipid synthesis in female adipocytes com-
pared with male adipocytes is attributable, at least in part,
to increased glucose transporters and lipogenic enzyme
levels.
Castration reverses lipogenic rates and gene
expression. To determine the role of estrogen and tes-
tosterone on the sexual dimorphism of lipogenesis and
insulin sensitivity, we analyzed the lipogenic capacity of
fat cells taken from mice 6 weeks after castration or sham
surgery. Adipocytes from castrated females had a de-
crease in the lipogenic rate (PG, P  0.01; SC, P  0.005)
and in insulin sensitivity (only in PG depot) when com-
pared with adipocytes from the sham controls, more
closely resembling those of male adipocytes. PG adipo-
cytes from castrated females had 47% lower rates of
maximal lipogenesis (P  0.05) compared with the control
females. The half maximal response occurred at 0.4 nmol/l
FIG. 3. Female adipocytes have increased mRNA protein expression of lipid and glucose metabolism genes. Adipocytes from PG and SC fat
isolated from male and female mice were lysed by homogenization using a denaturing guanidine-thiocyanate–containing buffer, mRNA was
extracted, and quantitative real-time PCR was performed (A). Gene expression for GLUT1, GLUT4, FAS, and ACC mRNAs were normalized
against the expression of TATA-binding protein. B: Proteins from similar adipocyte isolates were extracted and subjected to SDS-PAGE and
Western blotted with antibodies to each of these proteins. Actin was used as a control for protein loading. Each lane represents a pool of
adipocytes from three to four mice. C: The data were quantiﬁed by densitometry of immunoblots (n  3) and normalized against actin. *P < 0.05.
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although this difference was not statistically signiﬁcant. In
SC adipocytes from castrated females, both the basal and
the maximal lipogenesis stimulated by insulin was reduced
by 50% compared with control females (P  0.05), whereas
the half maximal response did not change and occurred at
0.5 nmol/l of insulin for both castrated and control animals
(Fig. 4A and C).
Adipocytes from castrated male mice, on the other
hand, showed increased lipogenic capacity and increased
insulin sensitivity when compared with controls (Fig. 4B
and D), similar to adipocytes from normal female mice.
These effects were observed in both the PG and the SC
depots. For male adipocytes, the half maximal lipogenesis
from PG and SC depots occurred at 0.5 and 0.6 nmol/l
insulin in controls, whereas in the cells from castrated
males, the half maximal response occurred at 0.05 nmol/l
(P  0.02) and 0.3 nmol/l (not signiﬁcant) insulin, respec-
tively. Basal lipogenesis was increased 250% (P  0.05) in
PG cells and 210% (P  0.05) in SC cells from castrated
animals compared with controls, whereas the maximal
lipogenesis was increased 200% in PG (P  0.05) and 225%
(not signiﬁcant) in SC cells from castrated males com-
pared with controls.
Quantitative RT-PCR analysis revealed that castration
also caused a decreased gene expression of GLUT1,
GLUT4, FAS, and ACC in female adipocytes from both
depots when compared with adipocytes from sham-oper-
ated mice, whereas in male adipocytes, the expression of
these genes increased in both depots after castration (Fig.
5A). Comparing adipocytes of the PG depot from castrated
females with those from sham controls, GLUT4, ACC, FAS,
and GLUT1 expression were reduced 35% (P  0.05), 55%
(P  0.05), 45% (P  0.05), and 44% (not signiﬁcant).
Likewise, in the SC depot from females, expression of the
lipogenic genes ACC and FAS was dramatically reduced,
whereas the expression of the glucose transporters 1 and
4 did not change after castration. In the case of the males,
PG adipocytes showed a trend to increased expression of
GLUT4, ACC, and FAS after castration; however, these
changes were not statistically signiﬁcant. On the other
hand, castration in male mice resulted in a 250–300%
increase in GLUT1, FAS, and ACC mRNA (P  0.05) in SC
adipocytes (Fig. 5A). Expression of the insulin receptor
itself did not change in any of the depots in males nor
females after castration (Fig. 5A). Western blot analysis of
PG adipocytes from males and females after castration or
sham surgery showed changes in agreement with the
mRNA levels (Fig. 5B and C).
Effect of castration on body weight, adipose tissue
weight, adipocyte size, and adipokine levels. Castra-
tion is known to have effects on body weight (15,16). In
these experiments, castration was performed at 9 weeks
and the studies done 6 weeks later at 15 weeks of age. At
this time, the average weight of the castrated males was
9.8% lower than the sham-operated control males (29.2 
2.0 g vs. 26.5  2.9 g; not signiﬁcant). On the other hand,
the average weight of the castrated females was 14.5%
higher than the control females (23.4  1.0 g vs. 26.8 
2.5 g; P  0.05). Regarding cell size, we observed that PG
AB
D C
FIG. 4. Castration reverses lipogenic rates in male and female adipocytes. Male and female mice were castrated or sham operated. Six weeks after
surgery, adipocytes from PG (A and B) and SC (C and D) fat were isolated and stimulated with or without insulin in the presence of
14C-glucose
for 90 min. Radioactivity was measured in the extracted lipids and normalized by total lipid content. n  6 animals per group. **P < 0.05 by
repeated-measures ANOVA. *P < 0.05 by Student’s t test for point-to-point comparisons sham versus castrated.
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cytes from the analogous depot in females (P  0.05). SC
adipocytes from males were only 20% bigger than SC
adipocytes from females. In females, PG adipocytes were
20% bigger than SC adipocytes, whereas in males, PG
adipocytes were 60% bigger than SC adipocytes (P  0.05)
(Fig. 6A). After castration, adipocytes in female PG and SC
depots increased in size by 70 and 50%, respectively (P 
0.05). In males, castration did not affect adipocyte size
signiﬁcantly, although there was a trend to decreased cell
size in both depots (Fig. 6A).
Similar results were observed in adipose tissue weight.
Male PG adipose tissue was double the size of female PG
adipose tissue (0.88  0.17 g vs. 0.47  0.03 g, respectively;
P  0.05). In contrast, male SC adipose tissue was only
25% bigger than female SC adipose tissue (0.63  0.13 g vs.
0.43  0.04 g). In males, the PG fat pad was 33% heavier
than the SC inguinal fat pad (P  0.05), whereas in
females, these two fat depots were of almost identical size
(Fig. 6B). Castration resulted in a doubling of the size of
both PG and SC fat pads in females (P  0.05), whereas in
males, there was no signiﬁcant change in either depot
weight after castration (Fig. 6B).
Factors that can modulate insulin sensitivity include the
adipokines leptin and adiponectin. Serum adiponectin
levels were increased in both males and females after
castration compared with control mice (P  0.05) with no
signiﬁcant difference between males and females (supple-
mental Fig. 1A, available in the online appendix). Leptin
levels tended to be higher in females than in males and
FIG. 5. Castration reverses gene expression patterns in male and female adipocytes. Male and female mice were castrated (C) or sham operated
(S). Six weeks after surgery, adipocytes from PG and SC fat were isolated, mRNA was extracted, and quantitative real-time PCR was performed
(A). Gene expression for metabolic genes was assessed and normalized against the expression of TATA-binding protein. B: Proteins from similar
cells were subjected to SDS-PAGE and Western blot with the respective antibodies. Actin was used as a control for protein loading. C:
Quantitation of the proteins was achieved by densitometry normalized by the values for actin. *P < 0.05. IR, insulin receptor.
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females, but these differences were not statistically signif-
icant (supplemental Fig. 1B of the online appendix).
Effect of different steroid levels on adipocyte lipo-
genesis in males and females. To assess more directly
the effect of sex steroids on insulin sensitivity, we mea-
sured lipogenic rates on adipocytes from castrated female
and male mice (with very low levels of estrogen or
testosterone), control mice (with normal levels of sex
steroids) and normal mice implanted for 3 weeks with
estrogen or 5-DHT (the most active metabolite of testos-
terone) pellets. As expected, estradiol and DHT levels
were dramatically reduced in castrated animals and in-
creased in implanted ones (supplemental Fig. 2 of the
online appendix). To minimize the effects of body weight
change after castration, we performed the lipogenesis
assays only 3 weeks after the surgery.
In females, estrogen treatment caused a signiﬁcant
decrease in the lipogenic rates in adipocytes from the PG
depot (P  0.005) (Fig. 7A). This was manifest by a 38%
decrease in insulin-stimulated lipogenesis in PG adipo-
cytes from estrogen-treated females compared with those
from controls (P  0.05). However, the half maximal
response occurred at 0.2 nmol/l insulin, similar to the
controls, showing that estrogen treatment does not alter
insulin sensitivity. Conversely, short-term castration de-
creased lipogenic rates in the PG adipocytes (P  0.01) as
seen in the previous experiments. Interestingly, short-term
castration did not alter insulin sensitivity in PG adipocytes
from females, because half maximal lipogenesis was sim-
ilar to those from controls, that is, 0.2 nmol/l insulin (Fig.
7A). In female SC adipocytes, on the other hand, there was
no signiﬁcant change in the lipogenic rates at the high
insulin concentrations after castration or estrogen treat-
ment (Fig. 7C). Although castrated females increased their
body weight by 12% (P  0.05) (Fig. 7E), only the PG
depot increased in weight (50%, P  0.05), whereas the
size of the SC depot did not change (Fig. 7F). Likewise,
females implanted with estrogen pellets showed a signiﬁ-
cant decrease in weight in the PG fat pad (35%, P  0.05)
but had no change in weight in the SC depot compared
with the controls or in total body weight.
In males, short-term castration caused the same effect
as the 6-week castration with increased lipogenic rates
and increased insulin sensitivity in both depots. In the PG
depot, basal and maximal lipogenesis were increased 230
and 171% (P  0.05), and in the SC depot, these rates
increased by 175 and 153% when compared with controls
(P  0.05). Insulin sensitivity also increased in adipocytes
from castrated males compared with controls. Half maxi-
mal lipogenesis in both depots occurred 0.1 nmol/l of
insulin in adipocytes from castrated males, similar to
control female PG fat, whereas in noncastrated controls,
half maximal stimulation was at 0.4 (PG; P  0.001) and
0.5 (SC; P  0.005) nM insulin (Fig. 7B and D). DHT
treatment did not cause any change in lipogenic rates or
insulin sensitivity in either adipose depot. DHT did
cause a nonsigniﬁcant 6% increase in body weight in
males with no changes in the adipose tissue weight (Fig.
7E and F).
Effect of sex steroid levels on adiponectin, leptin,
and free fatty acids. Changes in the level of sex steroids
had variable effects on levels of circulating adipokines.
Adiponectin levels tended to increase in castrated females
and were decreased by 60% in females implanted with
estradiol (P  0.05). In castrated males, adiponectin levels
were increased (P  0.05), and there was no change in
DHT-implanted males. Adiponectin levels were similar
between males and females. Leptin levels were not
changed by any of the treatments in males or females, and
the levels tended to be higher in females, but this differ-
ence was not statistically signiﬁcant. Free fatty acids were
not different between males and females and did not
change with any of the treatments (supplemental Fig. 3 of
the online appendix).
DISCUSSION
Adipose tissue plays a major role in the regulation of
glucose homeostasis and insulin sensitivity. Interestingly,
fat accumulation is sexually dimorphic. Females have a
higher percentage of body fat and tend to accumulate
more SC fat than males, whereas males have a lower
percentage of body fat and accumulate more visceral fat.
Despite the higher level of body fat, female humans and
rodents are more insulin sensitive than males. Thus,
women have improved glucose tolerance and increased
FIG. 6. Effect of castration on adipocyte size and adipose tissue weight.
Male and female mice were castrated (C) or sham operated (S). Six
weeks after surgery, total body weights and adipose tissue weights
from PG and SC fat were assessed, and adipocytes were isolated as
described in RESEARCH DESIGN AND METHODS. Mean cell size was calculated
by dividing the total lipid content by the total number of cells on a
sample. Graphs show the mean adipocyte size (A) or adipose tissue
weight (B) from six animals per group. *P < 0.05.
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more resistant to fatty acid–induced insulin resistance
(8,19,20). Prevalence of early abnormalities of glucose
metabolism is three times higher in men compared with
women (7). Likewise, female mice are less prone to
diet-induced insulin resistance (10,21,22), and many genet-
ically induced forms of insulin resistance have a milder
phenotype in females compared with males (11,21,22).
FIG. 7. Effect of short-term castration and steroid treatment on lipogenesis, body weight, and adipose tissue weight in males versus females. Male
and female mice were castrated, implanted with 17-estradiol or 5-DHT pellets, or sham operated. Three weeks after surgery, adipocytes from
PG (A and B) and SC (C and D) fat were isolated and stimulated with or without insulin in the presence of
14C-glucose for 90 min. Radioactivity
was measured in the extracted lipids and normalized by total lipid content. E and F: Total body weight (E) and adipose tissue weights (F) from
PG and SC fat from sham-operated (sham or S) castrated (cast or C) implanted with estrogen-containing pellets (E) or DHT-containing pellets
(T) were assessed. The graphs show the mean from eight animals per group. **P < 0.05 by repeated-measures ANOVA. *P < 0.05 by Student’s t
test for point-to-point comparisons.
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female versus male mice can be detected on simple
intraperitoneal glucose and insulin tolerance tests.
In the present study, we have further analyzed sex
differences in adipocyte glucose and lipid metabolism as
they relate to differences in insulin sensitivity at the
cellular level. We ﬁnd that adipocytes of female mice have
increased lipogenic capacity compared with adipocytes
from male mice and are also more insulin sensitive,
especially those from the intra-abdominal (PG) depot,
which are more insulin sensitive than female adipocytes
from the SC depot and male adipocytes from both depots.
This increased lipogenic capacity in female adipocytes is
the result of at least two factors. One is enhanced insulin
sensitivity at intermediate steps in the insulin signaling
network such as stimulation of Akt and ERK. Thus, PG
adipocytes from female mice show increased phosphory-
lation/activation of Akt at lower doses of insulin than male
adipocytes, and Akt has been shown to be a key interme-
diate in insulin stimulation of glucose transport (23). The
other factor is increased expression of glucose and lipid
metabolism genes such as GLUT1, GLUT4, FAS, and ACC.
Interestingly, despite the increased lipogenic rates, female
adipocytes are smaller than male adipocytes, especially
those from the PG depot, consistent with studies showing
that females adipocytes have increased lipolytic rates
compared with those from males (24,25). As a result, in
humans, females have higher FFA serum levels than males
(20) but appear to be protected against insulin resistance
induced by elevated FFA (8). However, in mice, we did not
detect any signiﬁcant differences in the FFA serum levels
between males and females.
Our results, as well as previous studies (26), demon-
strate that female adipocytes have increased insulin
sensitivity compared with male adipocytes. This is
particularly true for female PG adipocytes, which have a
lower EC50 (0.1–0.2 nmol/l insulin) for insulin stimulation
of lipogenesis than female SC adipocytes (0.5–0.6 nmol/l)
and male adipocytes from either depot (0.4–0.7 nmol/l).
Female PG adipocytes have a higher lipogenic rate than
male adipocytes. Because PG fat in females also has a
higher lipolytic capacity than in males (25), this would
suggest a higher metabolic turnover of PG fat in females
leading to decreased fat accumulation in visceral depots in
females compared with males.
Sex steroids are known to play a role in the regulation of
adipose tissue development and function as well as whole-
body insulin sensitivity. Ovariectomy reduced lipogenic
capacity in female adipocytes from both PG and SC depots
and reduced insulin sensitivity in female PG adipocytes,
indicating a positive role of estrogen in insulin sensitivity
and lipogenesis in females. The exact mechanism of this
effect is confounded by the fact that castration increases
food intake and fat mass in females, and this could
contribute indirectly to a reduction in insulin sensitivity.
To differentiate the direct hormonal effects from the
indirect effects on body weight, we shortened the period
after castration before analysis to 3 weeks. Under these
conditions, weight gain was reduced, and there was no
effect of ovariectomy on insulin sensitivity and a reduced
effect on lipogenesis, suggesting that body weight is a
factor affecting adipocyte insulin sensitivity, although es-
trogen deﬁciency may also play a role. Indeed, short-term
lack of estrogen after ovariectomy increased PG depot
weight and estrogen pellet implantation in normal mice
decreased PG depot weight as compared with controls.
Interestingly, both of these manipulations affected the SC
adipocytes in a similar fashion, whereas fat pad weight,
lipogenic rate, and insulin sensitivity remained the same.
Thus, an increase in circulating estrogen above the phys-
iological levels preferentially alters PG adipose tissue
metabolism, reducing lipogenic rates and depot size.
These ﬁndings are in agreement with previous reports (27)
and consistent with evidence that white adipocytes in
different fat depots have fundamentally different proper-
ties and may have different developmental lineage (28).
Which estrogen receptor (ER) is mediating these effects is
unclear. In females, ER expression is similar between
depots, whereas we and others found that the levels of
ER are higher in the SC depot (data not shown) (29).
Studies with knockout mice of ER or ER suggest that
the effects of estrogen in the adipose tissue are mediated
mainly through ER (30–32). The preferential effect of
estrogen on adipocyte metabolism in the PG depot in
females might also involve differences in coactivators such
as the steroid receptor coactivator p160 family of proteins
(33).
In male mice, androgen receptor expression is higher in
PG than SC fat (data not shown). Both short-term and
long-term castration in males resulted in increased insulin
sensitivity and increased lipogenesis in both PG and SC
depots. This was independent of changes in the adipose
tissue weight. Thus, in contrast to the preferential effect of
estrogen in females on the PG depot, testosterone exerts
an inhibitory effect on lipogenesis and insulin sensitivity in
both PG and SC adipocytes. These results are the opposite
of what happens in the androgen receptor knockout mice,
which develop late-onset obesity with reduced energy
expenditure (34). This difference in phenotypes might be
explained by the fact that obesity is observed in the ARKO
mice only in old mice (30 weeks old), suggesting that
factors related to aging are necessary for the development
of obesity in this context.
Adiponectin levels cannot explain the changes in insulin
sensitivity in females. Adiponectin levels were increased
in castrated females, but insulin sensitivity was decreased
in the adipocytes. In females implanted with estradiol,
adiponectin levels were decreased, but this was not re-
ﬂected in lower insulin sensitivity. In males, adiponectin
levels did increase after castration, which does correlate
with increased insulin sensitivity.
In summary, our results demonstrate an important role
for sex steroids and sex in modulating adipose mass and
insulin sensitivity. Thus, female adipocytes have increased
lipid synthesis compared with male adipocytes in both the
PG and SC depots, and in females, PG adipocytes also
have improved insulin sensitivity to lipogenesis and to
insulin signaling. These contribute to whole-body insulin
sensitivity, allowing female mice to remain insulin sensi-
tive despite similar or higher fat mass.
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